The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Highbridge Convertible Arbitrage Master Fund, L.p. since 2007.
The trader's CIK number is 1390331.
At the time of the last reporting, Highbridge Convertible Arbitrage Master Fund, L.p. was the 10% Owner of Enzon Pharmaceuticals, Inc.. (stock ticker symbol ENZN).
Also see all insider trading activities at Enzon Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | ENZN | 191,705 | $1,450,013 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-08-02 | ENZN | Buy | 60,000 | 7.21 | 432,600 |
| 2007-07-24 | ENZN | Buy | 55,000 | 7.71 | 424,050 |
| 2007-07-16 | ENZN | Buy | 22,192 | 7.75 | 171,988 |
| 2007-07-12 | ENZN | Buy | 500 | 7.71 | 3,855 |
| 2007-07-11 | ENZN | Buy | 54,013 | 7.73 | 417,520 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Highbridge Convertible Arbitrage Master Fund, L.p. (10% Owner of Enzon Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.